D. Brunner
Impact in
- Biochemistry top 2%
- Antioxidant Activity and Oxidative Stress
- Nephrology top 2%
- Dialysis and Renal Disease Management
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 20
-
- Cardiovascular Function and Risk Factors 3
- Lipid metabolism and disorders 3
- Co-authors
- Mona BoazTalia WeinsteinAdrian IainaUzi GafterAaron KnechtManfred S. GreenShmuel SmetanaZipora Matas
- Journals
- Atherosclerosis (4 papers)The Lancet (4 papers)The American Journal of Cardiology (3 papers)Cardiology (2 papers)International Journal of Cardiology (1 paper)
- Partner nations
- IsraelGermanyUnited Kingdom
In The Last Decade
D. Brunner
53 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Biochemistry 311
- Nephrology 317
- Endocrinology, Diabetes and Metabolism 474
- Cardiology and Cardiovascular Medicine 511
- Nutrition and Dietetics 335
Countries citing papers authored by D. Brunner
This map shows the geographic impact of D. Brunner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Brunner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Brunner more than expected).
Fields of papers citing papers by D. Brunner
This network shows the impact of papers produced by D. Brunner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Brunner. The network helps show where D. Brunner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside D. Brunner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2006 | 12 | |
| 3 | 2003 | 17 | |
| 4 | 2003 | 7 | |
| 5 | Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial Hit paper breakdown → | 2000 | 774 |
| 6 | 2000 | 17 | |
| 7 | 1998 | 2 | |
| 8 | 1997 | 26 | |
| 9 | 1997 | 9 | |
| 10 | THE RELATIVE ABSENCE OF VASCULAR DISEASE IN DIABETIC YEMENITE JEWS. I. A STUDY OF CLINICAL FINDINGS. | 1996 | 0 |
| 11 | 1996 | 16 | |
| 12 | 1991 | 15 | |
| 13 | 1989 | 34 | |
| 14 | 1988 | 5 | |
| 15 | The Role of exercise in internal medicine | 1977 | 2 |
| 16 | 1971 | 51 | |
| 17 | Prevention of recurrent myocardial infarction by physical exercise. | 1969 | 5 |
| 18 | 1960 | 37 | |
| 19 | 1959 | 11 | |
| 20 | [Cholesterol, phospholipids, total lipids and the cholesterol-phospholipid ratio in healthy males of various origin in Israel]. | 1955 | 7 |
About D. Brunner
D. Brunner is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Surgery, Cancer Research and Pharmacy, having authored 56 papers that have together received 2.0k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers), Lipoproteins and Cardiovascular Health (17 papers), Cancer, Lipids, and Metabolism (7 papers), Genetic Associations and Epidemiology (6 papers), Blood properties and coagulation (4 papers), Liver Disease Diagnosis and Treatment (3 papers), Cardiovascular Function and Risk Factors (3 papers) and Lipid metabolism and disorders (3 papers). The work is most often cited by research in Biochemistry (311 citations), Nephrology (317 citations), Endocrinology, Diabetes and Metabolism (474 citations), Cardiology and Cardiovascular Medicine (511 citations) and Nutrition and Dietetics (335 citations). D. Brunner has collaborated with scholars based in Israel, Germany and United Kingdom. Frequent co-authors include Mona Boaz, Talia Weinstein, Adrian Iaina, Uzi Gafter, Aaron Knecht, Manfred S. Green, Shmuel Smetana, Zipora Matas, M Fainaru and Uri Goldbourt. Their work appears in journals such as Atherosclerosis, The Lancet, The American Journal of Cardiology, Cardiology and International Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.